Anomalous Coronary Arteries: When to Follow-up, Risk Stratify, and Plan Intervention

Eduardo Leal Adam1, Giuliano Generoso2, Marcio Sommer Bittencourt3,4

  • 1Universidade Federal do Paraná, Curitiba, Paraná, Brazil.

Insights

Coronary artery anomalies require a standardized clinical approach for assessment and management. Recent data aids in identifying high-risk features for personalized patient care.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Clinical Medicine

Background:

  • Coronary artery anomalies present a spectrum from benign variations to critical conditions.
  • Current classification, risk stratification, and management lack universal consensus.
  • An individualized approach is essential for patient care.

Purpose of the Study:

  • To establish a straightforward clinical approach for assessing and managing patients with anomalous coronary arteries.
  • To synthesize recent findings to inform clinical practice.

Main Methods:

  • Review of recent autopsy series and population screening studies.
  • Analysis of data from coronary computed tomography angiography, magnetic resonance imaging, and invasive angiography.
  • Integration of physiological data, including fractional flow reserve and intravascular ultrasound.

Main Results:

  • Recent studies provide valuable data on prevalence and outcomes of coronary anomalies.
  • High-risk features associated with specific anomalies have been identified.
  • An individualized management strategy is supported by clinical, physiological, and anatomical data.

Conclusions:

  • A unified clinical approach is needed for anomalous coronary arteries.
  • Personalized management based on comprehensive patient data is crucial.
  • Further high-quality research is vital for advancing the field.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
83
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
431
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
58
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
562
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
125